<DOC>
	<DOC>NCT01171547</DOC>
	<brief_summary>The purpose is to investigate daptomycin pharmacokinetics in critically ill patients with suspected or verified bacteremia with Gram-positive cocci undergoing combined continuous hemodiafiltration at a filtration rate of 35ml/kg/h and to establish a dose recommendation for continuous hemodiafiltration at a filtrate rate of 35ml/kg/h.</brief_summary>
	<brief_title>Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>male or female of 18 years or older females: negative pregnancy test Hospitalisation in the medical ICU High suspicion or evidence of Grampositive infections requiring antibiotic therapy Subjects receiving standard antibiotic treatment for Grampositive infection Evidence of renal failure Clinical necessity for continuous renal replacement therapy Written informed consent signed by the patient or a next of kin and an independent physician in case the patient is not able to sign. Skeletal muscle disorders or CPK levels of &gt; 2 x ULN History of hypersensitivity to the drug Participation in another study Subjects with a history of muscle disease Patients with severe liver function impairment (Child C) Life expectancy of less than 5 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>pharmacokinetics</keyword>
</DOC>